DrugPatentWatch Database Preview
Selinexor - Generic Drug Details
What are the generic sources for selinexor and what is the scope of freedom to operate?
Selinexor
is the generic ingredient in one branded drug marketed by Karyopharm Theraps and is included in one NDA. There are six patents protecting this compound. Additional information is available in the individual branded drug profile pages.Selinexor has one hundred and three patent family members in thirty-five countries.
Summary for selinexor
| International Patents: | 103 |
| US Patents: | 6 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 32 |
| Clinical Trials: | 102 |
| Patent Applications: | 261 |
| What excipients (inactive ingredients) are in selinexor? | selinexor excipients list |
| DailyMed Link: | selinexor at DailyMed |
Recent Clinical Trials for selinexor
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Juan Du | Phase 2 |
| European Myeloma Network | Phase 3 |
| University of Colorado, Denver | Phase 2 |
US Patents and Regulatory Information for selinexor
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Karyopharm Theraps | XPOVIO | selinexor | TABLET;ORAL | 212306-003 | Apr 15, 2021 | RX | Yes | No | ⤷ Try it Free | ⤷ Try it Free | Y | Y | ⤷ Try it Free | ||
| Karyopharm Theraps | XPOVIO | selinexor | TABLET;ORAL | 212306-001 | Jul 3, 2019 | RX | Yes | Yes | ⤷ Try it Free | ⤷ Try it Free | ⤷ Try it Free | ||||
| Karyopharm Theraps | XPOVIO | selinexor | TABLET;ORAL | 212306-001 | Jul 3, 2019 | RX | Yes | Yes | ⤷ Try it Free | ⤷ Try it Free | ⤷ Try it Free | ||||
| Karyopharm Theraps | XPOVIO | selinexor | TABLET;ORAL | 212306-003 | Apr 15, 2021 | RX | Yes | No | ⤷ Try it Free | ⤷ Try it Free | Y | Y | ⤷ Try it Free | ||
| Karyopharm Theraps | XPOVIO | selinexor | TABLET;ORAL | 212306-004 | Apr 15, 2021 | RX | Yes | No | ⤷ Try it Free | ⤷ Try it Free | Y | Y | ⤷ Try it Free | ||
| Karyopharm Theraps | XPOVIO | selinexor | TABLET;ORAL | 212306-003 | Apr 15, 2021 | RX | Yes | No | ⤷ Try it Free | ⤷ Try it Free | ⤷ Try it Free | ||||
| Karyopharm Theraps | XPOVIO | selinexor | TABLET;ORAL | 212306-003 | Apr 15, 2021 | RX | Yes | No | ⤷ Try it Free | ⤷ Try it Free | ⤷ Try it Free | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for selinexor
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Chile | 2015001257 | ⤷ Try it Free |
| Australia | 2018204256 | ⤷ Try it Free |
| Poland | 2736887 | ⤷ Try it Free |
| Brazil | 112014001933 | ⤷ Try it Free |
| South Korea | 20140066179 | ⤷ Try it Free |
| Australia | 2018202441 | ⤷ Try it Free |
| Peru | 20141003 | ⤷ Try it Free |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for selinexor
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 2736887 | CA 2021 00031 | Denmark | ⤷ Try it Free | PRODUCT NAME: SELINEXOR ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF; REG. NO/DATE: EU/1/21/1537 20210329 |
| 2736887 | LUC00219 | Luxembourg | ⤷ Try it Free | PRODUCT NAME: SELINEXOR OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI; AUTHORISATION NUMBER AND DATE: EU/1/21/1537 20210329 |
| 2736887 | PA2021007 | Lithuania | ⤷ Try it Free | PRODUCT NAME: SELINEKSORAS; REGISTRATION NO/DATE: EU/1/21/1537 20210326 |
| 2736887 | 301119 | Netherlands | ⤷ Try it Free | PRODUCT NAME: SELINEXOR OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT ERVAN; REGISTRATION NO/DATE: EU/1/21/1537 20210329 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
